Table 3.
Genome-Wide Pharmacogenetic Studies from STEP-BD (2008–2013).
Author & Date | Sample Ethnic/Racial Composition |
Phenotype Studied |
GWAS-level significant variants | Ethnic/Racial Group differences |
---|---|---|---|---|
Perlis, et al. (2009) | N=1,177 | Recurrence of mood in after treatment lithium | None found | N/A |
Note. GWAS data obtained from the GWAS catalogue of the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (www.genome.gov/gwastudies). STEP-BD = Systematic Treatment Enhancement Program for Bipolar Disorder. Only studies with total sample sizes of 500 or more with prospectively assessed outcomes are included in this table.